Dr. rer. nat. Beate Henrichfreise
Group Leader
Research
Beate Henrichfreise studied biology and gained her PhD on antibiotic multi-resistance in Pseudomonas aeruginosa in 2006. In parallel to her PhD, she worked with Antiinfectives Intelligence, a service provider specialized in antiinfectives. Following a postdoctoral training at the Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, she joined industry in 2009 to gain experience in biotech and pharma industry working on peptides for technical and antimicrobial applications. Until 2012 she worked 50% at Novozymes A/S, Denmark at the Departments for Anti-Infective Discovery, Pharma Discovery and Peptide & Cell Discovery in the course of Marie Curie Actions and 50% at University Hospital Bonn to establish in parallel her independent field of basic research on cellular functions of peptidoglycan biosynthesis in cell wall lacking Chlamydiaceae. Returning to Germany for good in 2012, she attracted funding for a junior research group from the intramural funding scheme of the Medical Faculty of Bonn. In 2015 she became group leader at the inter-faculty Institute for Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn.Dr. rer. nat. Beate Henrichfreise
room 15
Meckenheimer Allee 168
53115 Bonn
Institut für Pharmazeutische Mikrobiologie
Universitätsklinikum Bonn
Universität Bonn
CV
2015 – date Group leader, University Hospital Bonn, University of Bonn, Institute for Pharmaceutical Microbiology
2012 – 2015 Junior research group leader, University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology
2011 – 2012 Research fellow, Peptide and Cell Discovery, Novozymes A/S, Bagsværd, Denmark
2010 – 2011 Postdoctoral fellow, University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology
2009 – 2010 Research fellow, Anti-Infective Discovery and Pharma Discovery, Novozymes A/S, Bagsværd, Denmark
2006 – 2009 Postdoctoral fellow, University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology
2002 – 2003 Deputy laboratory manager in part time, Antiinfectives Intelligence GmbH, Bonn
2006
PhD in Microbiology, University of Bonn, Pharmaceutical Microbiology
(Prof. Bernd Wiedemann)
2002
Diploma in biology, University of Bonn, Pharmaceutical Microbiology (Prof. Bernd Wiedemann)
1997 – 2002
Studies of Biology, University of Bonn
- European study group on Chlamydiales, Coxiella, Anaplasma, Rickettsia and other intracellular bacteria
- Paul-Ehrlich-Society of Chemotherapy e.V.
- Association for General and Applied Microbiology e.V.
- Society for Tropical Ecology e.V.
Funding
DFG TRR261 Antibiotic CellMAP - Cellular mechanisms of antibiotic action and production, project A07: Mechanisms of ß-lactam induced persistence in chlamydiae
Collaborative Research Grant, Emory University and University of Bonn, co-applicant
FEMHABIL, Medical Faculty, University of Bonn
DFG: Characterization of the chlamydial machinery for peptidoglycan remodelling
Maria von Linden program: support for accomplishing habilitation
BONFOR, Medical Faculty, University of Bonn: The chlamydial anomaly: processing and recycling of the cell wall building block lipid II in cell wall-lacking bacteria
Fonds der chemischen Industrie e.V.: “Sachkostenzuschuss für den Hochschullehrernachwuchs”
Distinctions and awards
2022 Scientific commitee, International Intracellular Bacteria Meeting 2022, Lausanne
2020 keynote lecture, German Chlamydia Workshop 2020, Lübeck
since 2017 Board member of the European study group on Chlamydiales, Coxiella, Anaplasma, Rickettsia and other intracellular bacteria
2016 Invited talk, EMBO conference on Bacterial Morphogenesis, Survival and Virulence: Regulation in 4D, Thiruvananthapuram, India
2016 Invited talk, EMBO Workshop ‘Bacterial cell division: orchestrating the ring cycle’, Prague, Czech Republic
2016 Support for accomplishing habilitation, Maria von Linden program, University of Bonn
2015 PHOENIX Pharmacy Research Award, category of pharmaceutical biology
2015 Co-chair, Chlamydia Basic research society meeting, Session ‘Inclusion Interactions’, New Orleans, USA
2012-2015 Junior research group funding from the intramural funding scheme of the Medical Faculty of Bonn, BONFOR
2012 ‘Sachkostenzuschuss für den Hochschullehrer-Nachwuchs’ from the ‘Fonds der chemischen Industrie e.V.’
2007 PhD award from the Paul-Ehrlich-Society for Chemotherapy e.V.
2004-2006 Doctoral fellowship from the ‘Studienstiftung des Deutschen Volkes’